| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.36 | 5e-08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.35 | 5e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |